Article
Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy.
Japanese journal of clinical oncology - 1 Apr 1996
Muro K, Ohtsu A, Boku N, Chin K, Oda Y, Fujii T, Hosokawa K, Yoshida S, Hasebe T
Abstract excerpt
Immunohistochemical analysis was performed to determine the clinical role of p53 mutations in patients with locally advanced esophageal carcinomas treated with concurrent chemoradiotherapy. The subjects of this study were 20 patients with previously untreated esophageal carcinomas with evidence o...
Topics
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Cisplatin
- Combined Modality Therapy
- Esophageal Neoplasms
- Fluorouracil
- Genes, p53
- Humans
- Immunohistochemistry
- Middle Aged
- Mutation
- Prognosis
- Prospective Studies